Search results
- 0.8967Add to watchlist+0.0066 (+0.74%)At close:4:00 PM EDTThu. May 30, 20240.8867 -0.01 (-1.12%)Pre mkt:7:00 AM EDTFri. May 31, 2024Nasdaq Real Time Price (USD) · Pre-Market Time
- Open0.9280High0.9280Low0.8800
- Mkt Cap3.42MP/E (TTM)N/ADiv & YieldN/A & N/A
- Prev. Close0.890152 Wk. Low0.500052 Wk. High8.6000
Related stocks
Avg. Volume 3,943,525. Market Cap (intraday) 3.481M. Beta (5Y Monthly) -- PE Ratio (TTM) -- EPS (TTM) -1.4500. Earnings Date Aug 12, 2024 - Aug 16, 2024. Forward Dividend & Yield -- Ex-Dividend...
1-year stock price forecast. INVO Competitors. $ Market cap P/E ratio $ Price 1d change 52-week range. View INVO Bioscience, Inc. INVO stock quote prices, financial information, real-time...
People also ask
Where can I buy INVO stock?
What does INVO stand for?
What is INVO Bioscience?
Does INVO Bioscience have a commercialization agreement with Ferring Pharmaceuticals?
Invo Bioscience Inc Stock Forecast, Predictions & Price Target. Overview Forecast Earnings Dividend Ownership. Be the first to know when Wall Street analysts revise their INVO stock forecasts and price targets. Get Free INVO Updates.
View live INVO BioScience, Inc. chart to track its stock's price action. Find market predictions, INVO financials and market news.
2 days ago · SARASOTA, Fla., May 15, 2024 (GLOBE NEWSWIRE) -- INVO Bioscience, Inc. (Nasdaq: INVO) ("INVO" or the "Company"), a healthcare services fertility company focused on expanding access to advanced treatme... 9 days ago - GlobeNewsWire. INVO Reports Fourth Quarter and Full Year 2023 Financial Results.
- 1.99M
- 3.02M
- 8.03M
- 1.09M
20.40 (2,192.13%) Estimated share price by August 2, 2024. Projected Revenue. 0 MM (-83.37%) Estimated quarterly revenue by December 31, 2022. Projected Earnings Per Share. -0.19 (0.23) Estimated quarterly earnings by December 31, 2022. Price Target. The average one-year price target for INVO Bioscience, Inc. is $20.4.
Apr 17, 2024 · INVO Stock Prediction 2024: Equity research analysts on and off Wall Street typically use earnings growth and fundamental research as a form of valuation and forecasting. But many in trading...